Welcome to the e-CCO Library!

P261: Asking about bowel control problems in IBD: Results of face-to-face screening vs. self-reporting
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Norton1*, A. Hart2, J. Duncan3, A. Emmanuel4, C. Knowles5, S. Kerry6, D. Lanz6, V. Berdunov6, V. Madurasinghe6, H. Terry7, A. Verjee8, L. Dibley9,10

Created: Thursday, 21 February 2019, 9:14 AM
P261: Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients – real world global study analyses
Year: 2022
Source: ECCO'22
Authors: Atreya, R.(1);Redondo, I.(2);Hill, J.(3);Streit, P.(4);Hartz, S.(5);Knight, H.(6);Barlow, S.(6);Hennessy, F.(6);Hunter, T.(7);
Created: Friday, 11 February 2022, 3:52 PM
P261: Clinical predictors of a frequently relapsing disease course under 5-ASA amongst ulcerative colitis patients initially responding to induction therapy with 5-ASA and/or steroids
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Atay*, Y. Erzin, I. Hatemi, T. Eskazan, I. Serin, S. Bozcan, N. Demir, A. F. Celik

Created: Friday, 22 February 2019, 9:49 AM
P261: Frequency of B-cell subsets in infliximab-treated paediatric IBD patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Schnell*1, B. Schwarz1, M. Wahlbuhl-Becker1, I. Allabauer1, T. Rechenauer1, G. Siebenlist1, S. Kaspar1, C. Ehrsam1, A. Rückel1, W. Rascher1, A. Hörning1

Created: Friday, 22 February 2019, 9:41 AM
P261: Grading post-operative recurrence in Crohn's disease: a comparison between MRE and ileocolonoscopy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lavelle A.*1, Keegan D.1, Byrne K.1, Sheridan J.1, Mulcahy H.1, Cullen G.1, Skehan S.2, Doherty G.A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P261: Predictors and outcomes of ustekinumab dose escalation to every 4 or every 6 weeks in ulcerative colitis: a multicenter cohort study in the United States
Year: 2021
Source: ECCO'21 Virtual
Authors: Dalal, R.(1);Esckilsen, S.(2);Barnes, E.(3);Pruce, J.(1);Marcus, J.(1);Allegretti, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P261: Rate of Community Acquired Pneumonia, related hospitalization, and mortality among younger unvaccinated Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khan, N.(1,2)*;Trivedi, C.(3);Shah, Y.(1);Patel, M.(1);Sundararajan, R.(1);Xie, D.(4);Yang , Y.X.(1,2);
Created: Friday, 14 July 2023, 11:05 AM
P262 Trends in the prevalence and severity of anaemia in paediatric patients with inflammatory bowel disease in the last decade
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S.Y. Geng, Z. Ridha, B.L. Pham, E. Tran, A. Peixoto, S.A. Tchogna, C. Deslandres, P. Jantchou

Created: Thursday, 30 January 2020, 10:12 AM
P262: Decreased infliximab trough levels (TLI) is a moderate predictor of loss of response to IFX in IBD patients.
Year: 2022
Source: ECCO'22
Authors: Roblin, X.(1);Berger, A.E.(2);Bastide, L.(1);Tournier, Q.(1);Veyrard, P.(1);Paul, S.(2);
Created: Friday, 11 February 2022, 3:52 PM
P262: Development and validation of a score predicting non-response to intravenous corticosteroids in patients with Acute Severe Ulcerative Colitis on day 3 of admission
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Subhaharan, D.(1)*;Ramaswamy, P.K.(1);Willmann, L.(1);Moattar, H.(1);Bhullar, M.(1);Ishaq, N.(1);Dorrington, A.(1);Shukla, D.(1);McIvor, C.(2);Edwards, J.(1);Mohsen, W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P262: Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry
Year: 2021
Source: ECCO'21 Virtual
Authors: Casas Deza, D.(1);Lamuela Calvo, L.J.(1);Arbonés Mainar, J.M.(2);Ricart, E.(3);Gisbert, J.P.(4);Rivero Tirado, M.(5);Sanchez Rodríguez, E.(6);Sicilia, B.(7);Gutierrez Casbas, A.(8);Merino Ochoa, O.(9);Márquez, L.(10);Laredo de la Torre, V.(11);Martin Arranz, M.D.(12);Lopez Serrano, P.(13);Riestra Menéndez, S.(14);Gonzalez Muñoza, C.(15);de Castro Parga, L.(16);Calvo Moya, M.(17);Garcia Alonso, J.(18);Esteve, M.(19);Iborra Colomino, M.(20);Dura Gil, M.(21);Barreiro de Acosta, M.(22);Lorente Poyatos, R.(23);Manceñido, N.(24);Caballo, B.(3);Calafat, M.(25);Rodríguez Lago, I.(26);Guardiola Capo, J.(27);Morales Alvarado, V.J.(28);Tardillo, C.(29);Bujanda, L.(30);Muñoz Nuñez, J.F.(31);Ber Nieto, Y.(32);Bermejo, F.(33);Chaparro, M.(4);Almela, P.(34);Navarro, M.(35);Domènech, E.(36);García López, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P262: Evaluation of zinc as a biomarker of a complicated course in paediatric Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ben Avraham S.*1, Sigall Boneh R.1, Cohen-Dolev N.1, Sarbagili-Shabat C.1, Levine A.2,3, Hussey S.4, Escher J.5, de Carpi J.M.6, Russell R.K.7 Porto-ECCO GROWTH CD Study Group

Created: Wednesday, 20 February 2019, 10:36 AM
P262: Influence of a positive family history on the clinical course of inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. W. Hwang*1, M. S. Kwak1, W. S. Kim1, J.-M. Lee1, S. H. Park1, H.-S. Lee1, D.-H. Yang1, K.-J. Kim1, B. D. Ye1, J.-S. Byeon1, S.-J. Myung1, Y. S. Yoon2, C. S. Yu2, J.-H. Kim1, S.-K. Yang1

Created: Friday, 22 February 2019, 9:49 AM
P262: New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Walsh1*, A. Kormilitzin2, C. Hinds3, V. Sexton4, S. Bond3, J. Wilson1, O. Brain1, S. Keshav1, H. Uhlig1, J. Geddes4, G. Goodwin4, M. Peters5, G. Collins6, S. Travis1

Created: Thursday, 21 February 2019, 9:14 AM
P262: Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: do we measure what we measure?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. van Andel*1, B. Koopmann1, D. van Asseldonk1, N. de Boer2, L. Mokkink3, C. Noomen1

Created: Friday, 22 February 2019, 9:41 AM
P263 Proximal disease extension in patients with ulcerative proctitis: Associated factors and experience of an IBD tertiary Brazilian centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Ferreira1, R. Queiróz Marques de Mendonça1, I. Steltenpool Tonin Borges1, P.H. de Avelar Cardoso1, L. Rose Otoboni Aprile1, R. Serafim Parra2, M. Ribeiro Feitosa2, O. Feres2, J.J. Ribeiro da Rocha2, L.E. de Ameida Troncon1

Created: Thursday, 30 January 2020, 10:12 AM
P263: De-novo inflammatory bowel disease after bariatric surgery: a novel association
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Braga Neto M.B., Loftus E., Bruining D., Bazerbachi F., Abu Dayyeh B., Raffals L., Deepak P.

Created: Wednesday, 20 February 2019, 10:36 AM
P263: Association between inflammatory bowel diseases and the non-classical histocompatibility complex HLA-G
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. da Costa Ferreira1, I. Abiodoun Sadissou2, R. Serafim Parra3, M. Ribeiro Feitosa3, F. Santos Lizarte Neto4, D. Pretti da Cunha Tirapelli4, L. Naira Zambelli Ramalho5, O. Féres3, E. Antônio Donadi2, L. E. de Almeida Troncon1

Created: Friday, 22 February 2019, 9:41 AM
P263: Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Saraiva*, J. Cortez-Pinto, R. Barosa, J. Castela, I. Rosa, J. Pereira da Silva, A. Dias Pereira

Created: Thursday, 21 February 2019, 9:14 AM
P263: Influence of Crohn´s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Chaparro, M.(1);Bastón Rey, I.(2);Fernández-Salgado, E.(3);González García, J.(4);Ramos, L.(5);Diz-Lois Palomares, M.T.(6);Argüelles, F.(7);Iglesias Flores, E.(8);Cabelo, M.(9);Rubio Iturria, S.(10);Núñez Ortiz, A.(11);Charro, M.(12);Ginard, D.(13);Dueñas Sadornil, C.(14);Merino Ochoa, O.(15);David, B.(16);Iyo, E.(17);Gutiérrez Casbas, A.(18);Ramírez de la Piscina, P.(19);Boscá-Watts, M.M.(20);Arroyo, M.(21);García, M.J.(22);Hinojosa, E.(23);Gordillo, J.(24);Martínez Montiel, P.(25);Velayos Jiménez, B.(26);Quílez Ivorra, C.(27);Vázque morón, J.M.(28);Huguet, J.M.(29);González Lama, Y.(30);Muñagorri Santos, A.I.(31);Amo, V.M.(32);Martín Arranz, M.D.(33);Bermejo, F.(34);Martínez Cadilla, J.(35);Fradejas Salazar, P.(36);Novella, C.(37);Vispo, E.(37);Barreiro-de Acosta, M.(2);P. Gisbert, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM